| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9844 | 
      | Human Intestinal Absorption | HIA+ | 0.9944 | 
      | Caco-2 Permeability | Caco2+ | 0.6161 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7214 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7183 | 
                                                     | Non-inhibitor | 0.8907 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9207 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8693 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8987 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9069 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6639 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7539 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8885 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9310 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8446 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9253 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7783 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9679 | 
                                                                    | Non-inhibitor | 0.9062 | 
      | AMES Toxicity | Non AMES toxic | 0.9528 | 
      | Carcinogens | Carcinogens  | 0.6969 | 
      | Fish Toxicity | High FHMT | 0.5673 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8608 | 
      | Honey Bee Toxicity | High HBT | 0.7471 | 
      | Biodegradation | Ready biodegradable | 0.9578 | 
      | Acute Oral Toxicity | III | 0.7985 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5187 |